YCH1899 is an orally active PARP inhibitor with IC50 values against PARP1/2 both less than 0.001 nM; it exhibits potent antiproliferative activity against Olaparib-resistant (Capan-1/OP) and Talazoparib-resistant (Capan-1/TP) Capan-1 cells, with IC50 values of 0.89 nM and 1.13 nM, respectively.